Last updated: 2026-09-16 10:31:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Accuray Incorporated (ARAY) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.25, with a market capitalisation of $29.30M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.22 to $2.10. This page covers its latest market performance, valuation, price trends and company information.
$29.30M | |
$0.23 | |
$31.09 | |
$0.22 | |
$0.23 | |
37.00 | |
1.26M | |
-- | |
$2.10 | |
$0.22 | |
-- | |
-- |
Accuray Incorporated (ARAY) is trading at $0.25 in pre-market trading as of 2026-09-16 10:22:00, up 8.46% ($0.02) from the previous close of $0.23
Pre-market trading shows how investors are pricing ARAY before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Accuray Incorporated (ARAY) moved from $0.27 to $0.25, representing a decline of 6.30% ($0.02).
The stock traded between $0.23 and $0.28 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 451.46 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.6%
ARAY is currently trading at $0.25, placing it 1.6% of the way from its 52-week low of $0.22 to its 52-week high of $2.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 809 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Accuray Incorporated (ARAY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.